【24h】

Catheter Ultrasound for Cross-sectional Imaging and Drug Delivery to Vessel Wall

机译:用于截面成像和药物输送至血管壁的导管超声检查

获取原文
获取原文并翻译 | 示例

摘要

Current methods for delivery of an anti-restenosis drug to an arterial vessel wall post-percutaneous transluminal angioplasty and stent placement are limited in terms of drug choice, dosing level, and ability to assure drug coverage between the struts of a drug eluting stent. Intravascular ultrasound (IVUS) provides real-time, radiation-free, imaging and assessment of atherosclerotic disease in terms of anatomical, functional and molecular information. In this presentation, the design of a dual imaging / therapy IVUS catheter is described and results documenting gene and drug delivery reported. Microbubbles and drug / gene (shell associated or co-injected) are dispensed from the catheter tip. Using this approach, it becomes possible to address the need for complete vessel wall coverage and achieve delivery in regions poorly addressed using conventional stent-based approaches. A range of in vitro, ex vivo and in vivo results are presented. Our most recent results involve a demonstration in a pig model of coronary balloon angioplasty that produced a 33% reduction in neointima formation versus a drug plus microbubble, but no ultrasound, control.
机译:在药物选择,给药水平以及确保药物洗脱支架的支杆之间的药物覆盖能力方面,目前用于将抗再狭窄药物递送至动脉血管壁的经皮腔内血管成形术和支架放置的方法受到限制。血管内超声(IVUS)可从解剖学,功能和分子信息方面对动脉粥样硬化疾病进行实时,无辐射的成像和评估。在本演示中,描述了双重成像/治疗IVUS导管的设计,并报告了记录基因和药物传递的结果。从导管尖端分配微泡和药物/基因(与壳相关或共同注射)。使用这种方法,有可能满足对完整血管壁覆盖的需求,并在使用常规基于支架的方法难以解决的区域中实现输送。提出了一系列的体外,离体和体内结果。我们的最新结果涉及在猪冠状动脉球囊成形术模型中的演示,与药物加微泡相比,超声内镜的形成使新内膜形成减少了33%,但没有超声控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号